An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer

An antibody-drug conjugate designed through clone and isotype selection restricts the growth of CSPG4-expressing triple-negative breast cancer

Esapa, B., Liu, Y., Chenoweth, A. M., Stoker, K., Łabędź, N., Romero-Clavijo, P., Ilieva, K. M., Trendell, J., Navarro-Llinas, B., Suriawinata, E., Butcher, T., Wang, N., Grandits, M., Palhares, L. C. G. F., McCraw, A., Crescioli, S., Johansson, A., Irshad, S., Grigoriadis, A. & Gazinska, P. & 7 others, Tsoka, S., Chudasama, V., Baker, J. R., Tutt, A. N. J., Cheung, A., Thurston, D. E. & Karagiannis, S. N., 7 Mar 2026, (E-pub ahead of print) In: NPJ precision oncology.

Research output: Contribution to journal › Article › peer-review